DETECTR
Recruiting
1,000 enrolled
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
Recruiting
25 enrolled
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
Active not recruiting
240 enrolled
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
Active not recruiting
1,410 enrolled
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Recruiting
480 enrolled
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed
377 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
Enrolling by invitation
1,000 enrolled
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Not yet recruiting
25 enrolled
FERTILE
Not yet recruiting
75 enrolled
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Active not recruiting
1,336 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Completed
354 enrolled
TraveraRTGx
Completed
72 enrolled
PROBE-II
Recruiting
1,300 enrolled
IGNITE-V
Phase 2 Recruiting
58 enrolled
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Completed
200 enrolled
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Recruiting
100 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
Recruiting
300 enrolled
PROACTION:
Recruiting
4,500 enrolled
SENTRY
Recruiting
245 enrolled
SHAPE-ENDO
Not yet recruiting
82 enrolled
CASCADE3002
Not yet recruiting
103 enrolled
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
Completed
119 enrolled
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Enrolling by invitation
500 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
Terminated
24 enrolled
MUSE-OVARY
Enrolling by invitation
12 enrolled
HPV-Vac-S
Recruiting
5,500 enrolled
PaPCR
Completed
45 enrolled
Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
Recruiting
30 enrolled
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Recruiting
1,715 enrolled
DP-04
Recruiting
100 enrolled
Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women
Recruiting
215 enrolled
OVAmiARN
Active not recruiting
746 enrolled
Estrogen, Diet, Genetics and Endometrial Cancer
Active not recruiting
1,315 enrolled
ASAP
Recruiting
25,000 enrolled
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Completed
460 enrolled 7 charts
(CLOCS-2)
Recruiting
2,900 enrolled
HART
Recruiting
120 enrolled
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
Recruiting
18 enrolled
3D-PEDSURG
Recruiting
60 enrolled
OSNA
Completed
108 enrolled
OLIVIA
Recruiting
250 enrolled
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Suspended
22 enrolled
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Completed
51 enrolled 28 charts
The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.
Completed
34 enrolled
PRO-ACTIVE
Recruiting
850 enrolled